we appreciate the great effort of the scientific community in the search for prevention and cure for Covid-19 through well-designed studies; on the other hand, we firmly believe that the pandemic-generated focus on antimalarials should not penalise patients with rheumatological diseases, in whom such drugs have widely demonstrated their benefits.
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)' by Moiseev et al / Spinelli, F. R.; Ceccarelli, F.; Di Franco, M.; Conti, F.. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 80:2(2021). [10.1136/annrheumdis-2020-217636]
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)' by Moiseev et al
Spinelli F. R.
;Ceccarelli F.;Di Franco M.;Conti F.
2021
Abstract
we appreciate the great effort of the scientific community in the search for prevention and cure for Covid-19 through well-designed studies; on the other hand, we firmly believe that the pandemic-generated focus on antimalarials should not penalise patients with rheumatological diseases, in whom such drugs have widely demonstrated their benefits.File | Dimensione | Formato | |
---|---|---|---|
Spinelli_Response_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
208.4 kB
Formato
Adobe PDF
|
208.4 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.